Respiratory Compromise Institute

"Almost all children get infected with respiratory syncytial virus (RSV) at least once before they are 2 years old. For most healthy children, RSV is like a cold. But some children get very sick with RSV."

New parents can take preventative measures before their newborn is brought into the world - They just have to know when and how.

Read more - https://www.healthychildren.org/English/health-issues/conditions/chest-lungs/Pages/RSV-When-Its-More-Than-Just-a-Cold.aspx

Please join the California Thoracic Society for a special educational webinar and LIVE Q&A on October 25th, at 5pm PT.⁣⁣
🔗 https://us06web.zoom.us/webinar/register/WN_hhguooORQa-AQ5WJtcqq4A

Topic: COPD with Type 2 Inflammation: A Spark For Deeper COPD Understanding
Speaker: Joseph E. Khabbaza, MD – Cleveland Clinic Foundation – Respiratory Institute
Q&A: There will be an opportunity for live Q&A at the conclusion of the formal presentation.

Developed by the California Thoracic Society in collaboration with Regeneron Pharmaceuticals Inc.

Explore new, advanced diagnostic software technologies during an educational webinar & LIVE Q&A with the California Thoracic Society:
🗓️ Friday, September 27th at 5pm PT.⁣
🔗 RSVP TODAY - https://bit.ly/3MLGa9K

Attendees will learn about highly detailed lung ventilation assessments and the precise quantification of lung volumes and other parameters, including areas of the lung with abnormal tissue density, that can provide actionable input for diagnoses.

Additionally, the session will demonstrate how to integrate these technologies to effectively triage patients presenting with unexplained dyspnea.

This is a non-CME event.

Developed by the California Thoracic Society in collaboration with 4DMedical.

The 3rd week of September is commonly referred to as "asthma peak week".

Here are some helpful tips the American Lung Association is sharing for parents to keep their children safe and healthy all year long.

Read more: https://www.lung.org/blog/asthma-back-to-school-tips

"AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy designed for quicker liberation from mechanical ventilation"

Read more: https://www.biospace.com/drug-development/lungpacer-medical-announces-pma-submission-for-aeropace-system